Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model
Frontiers in Pharmacology · 17.09.2024 · 15
DOI: 10.3389/fphar.2024.1464145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.09.2024. Verfasst von Qingliu He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The role of focal amplifications and extrachromosomal circular DNA (eccDNA) is still uncertain in prostate adenocarcinoma (PRAD). Here, we first mapped the global characterizations of eccDNA and then investigate the characterization of eccDNA-amplified key differentially expressed encoded genes (eKDEGs) in the progression, immune response and immunotherapy of PRAD.
Methods
Circular_seq was used in conjunction with the TCGA-PRAD transcriptome dataset to sequence, annotate, and filter for eccDNA-amplified differentially expressed coding genes (eDEGs) in PRAD and para-cancerous normal prostate tissues. Afterwards, risk models were created and eKDEGs linked to the PRAD prognosis were identified using Cox and Lasso regression analysis. The immune microenvironment of the risk model was quantified using a variety of immunological algorithms, which also identified its characteristics with regard to immunotherapy, immune response, and immune infiltration.
Results
In this research, there was no significant difference in the size, type, and chromosomal distribution of eccDNA in PRAD and para-cancerous normal prostate tissues. However, 4,290 differentially expressed eccDNAs were identified and 1,981 coding genes were amplified. Following that, 499 eDEGs were tested in conjunction with the transcriptome dataset from TCGA-PRAD. By using Cox and Lasso regression techniques, ZNF330 and PITPNM3 were identified as eKDEGs of PRAD, and a new PRAD risk model was conducted based on this. Survival analysis showed that the high-risk group of this model was associated with poor prognosis and validated in external data. Immune infiltration analysis showed that the model risks affected immune cell infiltration in PRAD, not only mediating changes in immune cell function, but also correlating with immunophenotyping. Furthermore, the high-risk group was negatively associated with anti- CTLA-4 /anti- PD-1 response and mutational burden. In addition, Tumor Immune Dysfunction and Exclusion analyses showed that high-risk group was more prone to immune escape. Drug sensitivity analyses identified 10 drugs, which were instructive for PRAD treatment.
Conclusion
ZNF330 and PITPNM are the eKDEGs for PRAD, which can be used as potential new prognostic markers. The two-factor combined risk model can effectively assess the survival and prognosis of PRAD patients, but also can predict the different responses of immunotherapy to PRAD patients, which may provide new ideas for PRAD immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
- Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Urology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Nursing, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Zitieren
APA
He, Q., Su, Q., Wei, C., Zhang, P., Liu, W., Chen, J., Su, X., & Zhuang, W. (2024). Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1464145
Vancouver
He Q, Su Q, Wei C, Zhang P, Liu W, Chen J, et al. Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1464145
BibTeX
@article{He2024,
author = {He, Qingliu and Su, Qingfu and Wei, Chengcheng and Zhang, Pu and Liu, Weihui and Chen, Junyi and Su, Xiaoping and Zhuang, Wei},
title = {Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1464145}
}
EUVIMED